Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy

by Kadowaki, Shigenori, Yatabe, Yasushi, Nitta, Sohei, Ito, Yuichi, Muro, Kei
Published 2014

Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy

by Mitani, Seiichiro, Kadowaki, Shigenori, Taniguchi, Hiroya, Muto, Hisanori, Muro, Kei
Published 2016

FOLFIRI Plus Bevacizumab 5 mg/kg Versus 10 mg/kg as Second-line Therapy in Patients with Metastatic Colorectal Cancer Who Have Failed First-line Bevacizumab Plus Oxaliplatin-based...

by Mishima, Hideyuki, Oba, Koji, Sakamoto, Junichi, Muro, Kei, Yoshino, Takayuki, Hyodo, Ichinosuke, Maehara, Yoshihiko
Published 2012

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

by Boku, Narikazu, Muro, Kei, Machida, Nozomu, Hashigaki, Satoshi, Kimura, Nobuyuki, Suzuki, Mie, Lechuga, Mariajose, Miyata, Yoshinori
Published 2013

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma

by Kadowaki, Shigenori, Yatabe, Yasushi, Hirakawa, Hitoshi, Komori, Azusa, Kondoh, Chihiro, Hasegawa, Yasuhisa, Muro, Kei
Published 2013

Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study

by Kondoh, Chihiro, Shitara, Kohei, Nomura, Motoo, Takahari, Daisuke, Ura, Takashi, Tachibana, Hiroyuki, Tomita, Natsuo, Kodaira, Takeshi, Muro, Kei
Published 2015

Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients11

by Taniguchi, Hiroya, Yamazaki, Kentaro, Yoshino, Takayuki, Muro, Kei, Yatabe, Yasushi, Watanabe, Toshiaki, Ebi, Hiromichi, Ochiai, Atsushi, Baba, Eishi, Tsuchihara, Katsuya
Published 2015

Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer

by Sasaki, Yasutsuna, Nishina, Tomohiro, Yasui, Hirofumi, Goto, Masahiro, Muro, Kei, Tsuji, Akihito, Koizumi, Wasaburo, Toh, Yasushi, Hara, Takuo, Miyata, Yoshinori
Published 2014

Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese...

by Doi, Toshihiko, Muro, Kei, Yoshino, Takayuki, Fuse, Nozomu, Ura, Takashi, Takahari, Daisuke, Feng, Hwa-ping, Shimamoto, Takashi, Noguchi, Kazuo, Ohtsu, Atsushi
Published 2013

Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients†

by Boku, Narikazu, Sugihara, Kenichi, Kitagawa, Yuko, Hatake, Kiyohiko, Gemma, Akihiko, Yamazaki, Naoya, Muro, Kei, Hamaguchi, Tetsuya, Yoshino, Takayuki, Yana, Ikuo, Ueno, Hiroshi, Ohtsu, Atsushi
Published 2014

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

by Nishina, Tomohiro, Takano, Yoshinao, Denda, Tadamichi, Yasui, Hisateru, Takeda, Koji, Ura, Takashi, Esaki, Taito, Okuyama, Yusuke, Kondo, Ken, Takahashi, Yasuo, Sugiyama, Yasuyuki, Muro, Kei
Published 2013

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

by Yamaguchi, Kazuhisa, Taniguchi, Hiroya, Komori, Azusa, Narita, Yukiya, Nitta, Sohei, Nomura, Motoo, Kadowaki, Shigenori, Takahari, Daisuke, Ura, Takashi, Andoh, Masashi, Muro, Kei, Mori, Keita, Igarashi, Yoshinori
Published 2015

Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment

by Okusaka, Takuji, Otsuka, Taiga, Ueno, Hideki, Mitsunaga, Shuichi, Sugimoto, Rie, Muro, Kei, Saito, Isao, Tadayasu, Yusuke, Inoue, Kohei, Loembé, Arsene‐Bienvenu, Ikeda, Masafumi
Published 2016

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

by Kiyota, Naomi, Schlumberger, Martin, Muro, Kei, Ando, Yuichi, Takahashi, Shunji, Kawai, Yasukazu, Wirth, Lori, Robinson, Bruce, Sherman, Steven, Suzuki, Takuya, Fujino, Katsuki, Gupta, Anubha, Hayato, Seiichi, Tahara, Makoto
Published 2015

Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study

by Yoshino, Takayuki, Muro, Kei, Yamaguchi, Kensei, Nishina, Tomohiro, Denda, Tadamichi, Kudo, Toshihiro, Okamoto, Wataru, Taniguchi, Hiroya, Akagi, Kiwamu, Kajiwara, Takeshi, Hironaka, Shuichi, Satoh, Taroh
Published 2015

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

by Tahara, Makoto, Fuse, Nozomu, Mizusawa, Junki, Sato, Akihiro, Nihei, Keiji, Kanato, Keisuke, Kato, Ken, Yamazaki, Kentaro, Muro, Kei, Takaishi, Hiromasa, Boku, Narikazu, Ohtsu, Atsushi
Published 2015

Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802)

by Suenaga, Mitsukuni, Nishina, Tomohiro, Mizunuma, Nobuyuki, Yasui, Hisateru, Ura, Takashi, Denda, Tadamichi, Ikeda, Junichi, Esaki, Taito, Nishisaki, Hogara, Takano, Yoshinao, Sugiyama, Yasuyuki, Muro, Kei
Published 2015

A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy

by Kim, Yeul Hong, Muro, Kei, Yasui, Hirofumi, Chen, Jen-Shi, Ryu, Min-Hee, Park, Se-Hoon, Chu, Kent-Man, Choo, Su-Pin, Sanchez, Teresa, DelaCruz, Christine, Mukhopadhyay, Pralay, Lainas, Ioannis, Li, Chung-Pin
Published 2012

Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients

by Kageyama, Shinichi, Wada, Hisashi, Muro, Kei, Niwa, Yasumasa, Ueda, Shugo, Miyata, Hiroshi, Takiguchi, Shuji, Sugino, Sahoko H, Miyahara, Yoshihiro, Ikeda, Hiroaki, Imai, Naoko, Sato, Eiichi, Yamada, Tomomi, Osako, Masaharu, Ohnishi, Mami, Harada, Naozumi, Hishida, Tadashi, Doki, Yuichiro, Shiku, Hiroshi
Published 2013

Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild‐type KRAS colorectal cancer‐WJOG 6210G

by Shitara, Kohei, Yonesaka, Kimio, Denda, Tadamichi, Yamazaki, Kentaro, Moriwaki, Toshikazu, Tsuda, Masahiro, Takano, Toshimi, Okuda, Hiroyuki, Nishina, Tomohiro, Sakai, Kazuko, Nishio, Kazuto, Tokunaga, Shoji, Yamanaka, Takeharu, Boku, Narikazu, Hyodo, Ichinosuke, Muro, Kei
Published 2016